Mostrando 6 resultados de: 6
Filtros aplicados
Publisher
American Journal of Clinical Nutrition(1)
Cardiovascular Diabetology(1)
European Heart Journal(1)
The BMJ(1)
The Lancet(1)
Área temáticas
Enfermedades(5)
Medicina forense; incidencia de enfermedades(2)
Salud y seguridad personal(2)
Medicina y salud(1)
Association of nut intake with risk factors, cardiovascular disease, and mortality in 16 countries from 5 continents: Analysis from the Prospective Urban and Rural Epidemiology (PURE) study
ReviewAbstract: Background: The association of nuts with cardiovascular disease and deaths has been investigated mosPalabras claves:Cardiovascular disease, Global Health, Mortality , nuts, prospective cohortAutores:Ahmed S.H., Alhabib K.F., Altuntas Y., Amma L.I.K.R., Anand S.S., Bangdiwala S.I., Basiak-Rasała A., Dagenais G.R., De Souza R.J., Dehghan M., DIaz R., Ismail R., Kelishadi R., Khatib R., Lear S.A., Mente A., Mohan V., PATRICIO LOPEZ -JARAMILLO, Poirier P., Rangarajan S., Rosengren A., Swaminathan S., Teo K.K., Wentzel-Viljoen E., Yeates K.E., Yusuf R., Yusuf S.Fuentes:googlescopusAssociations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies
ArticleAbstract: Background Several studies reported a U-shaped association between urinary sodium excretion and cardPalabras claves:Autores:Anand S.S., Avezum A.J., Bahonar A., Chifamba J., Dagenais G.R., DIaz R., Iqbal R., Lanas F., Lear S.A., Li W., Lu Y., Mann J.F.E., McQueen M.J., Mente A., Mony P.K., Oguz A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Rensheng L., Rosengren A., Schutte A.E., Szuba A., Teo K.K., Yi S., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M.Fuentes:googlescopusMortality and cardiovascular and respiratory morbidity in individuals with impaired FEV <inf>1</inf> (PURE): an international, community-based cohort study
ArticleAbstract: Background: The associations between the extent of forced expiratory volume in 1 s (FEV 1 ) impairmePalabras claves:Autores:Avezum A.J., Bahonar A., Chifamba J., Dagenais G.R., du Plessis J.L., Duong M.L., Gupta R., Igumbor E.U., Iqbal R., Islam S., Karsidag K., Killian K., Kumar R., Kurmi O.P., Lamelas P.M., Lanas F.T., Lear S.A., Leong D.P., Li W., Lu Y., Mohan V., Mony P.K., Nair S., Noorhassim I., O'Byrne P.M., PATRICIO LOPEZ -JARAMILLO, Rahman O., Rangarajan S., Rosengren A., Teo K.K., Wielgosz A., Yan R., Yusoff K., Yusuf S., Yusufali A.M., Zatońska K., Zhi F.Fuentes:googlescopusLowering cholesterol, blood pressure, or both to prevent cardiovascular events: Results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants
ArticleAbstract: Aims: Rosuvastatin (10 mg per day) compared with placebo reduced major adverse cardiovascular (CV) ePalabras claves:Cardiovascular disease, Primary Prevention, statinsAutores:Avezum A.J., Bosch J.J., Dagenais G.R., Dans A.M., DIaz R., Held C., Jansky P., Joseph P.G., Jung H., Keltai K., Keltai M., Khunti K., Leiter L.A., Lewis B.S., Liu L., Lonn E.M., Pais P., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Peters R.J.G., Piegas L.S., Reid C.M., Sliwa K., Toff W.D., Varigos J.D., Xavier D., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusJoint association of urinary sodium and potassium excretion with cardiovascular events and mortality: Prospective cohort study
ArticleAbstract: Objective: To evaluate the joint association of sodium and potassium urinary excretion (as surrogatePalabras claves:Autores:Alhabib K.F., Avezum A.J., Chifamba J., Dagenais G.R., Dans A.M., DIaz R., Ferguson J., Iqbal R., Khatib R., Kruger L., Lanas F.T., Lear S.A., Liu X., McQueen M.J., Mente A., Mohammadifard N., Noorhassim I., O'Leary N., Oguz A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Rosengren A., Smyth A., Swaminathan S., Szuba A., Teo K.K., Wielgosz A., Yeates K.E., Yin L., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M.Fuentes:googlescopusTotal cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis
ArticleAbstract: Background: The Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) doublePalabras claves:Cardiovascular disease, Glucagon like peptide-1 receptor agonists, Type 2 DiabetesAutores:Atisso C.M., Basile J.N., Colhoun H.M., Conget I., Cushman W.C., Dagenais G.R., Dyal L., Gerstein H.C., Hall S., Keltai M., Lakshmanan M., Lanas F.T., Leiter L.A., Munoz E.G.C., Pais P., PATRICIO LOPEZ -JARAMILLO, Pirags V., Pogosova N., Probstfield J.L., Raubenheimer P.J., Riddle M.C., Rydén L.E., Shaw J.E., Sheu W.H.H., Temelkova-Kurktschiev T.Fuentes:googlescopus